Advances in Bile Acid Metabolites and Their Receptor-Targeted Interventions in Chronic Kidney Disease

Chronic kidney disease (CKD) has traditionally been understood from a glomerular perspective: proteinuria and a decline in estimated glomerular filtration rate (eGFR) are regarded as core hallmarks of the disease, and current intervention options for CKD are limited.Recent studies have highlighted the critical role of the gut-kidney axis in the pathogenesis and management of CKD; metabolomics has shown that the accumulation of conjugated bile acids is associated with declining renal function and cardiovascular risk, whereas elevated levels of primary bile acids are associated with a lower risk of the disease.Research data, primarily from animal and cell culture models, indicate that bile acids (BAs) can influence CKD through the nuclear farnesoid X receptor (FXR) and the membrane G protein-coupled bile acid receptor (TGR5),This article provides a systematic review centered on the gut-kidney-vascular axis mediated by bile acid metabolites, elucidating the mechanisms of bile acid homeostasis remodeling and tissue damage in CKD, and highlighting that disease modification requires simultaneous targeting of specific bile acid subtypes and their receptors, rather than relying solely on existing therapies.

Authors

Institutions

Publication Details

Journal
Medicine insights.
Published
2026-11-18
DOI
https://doi.org/10.70088/8ksgw627
Primary Topic
Drug Transport and Resistance Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Advances in Bile Acid Metabolites and Their Receptor-Targeted Interventions in Chronic Kidney Disease

Jiangwa Xing, Yi You, Mingxiao Wang
5 links
Medicine insights.
Drug Transport and Resistance Mechanisms
article

Advances in Bile Acid Metabolites and Their Receptor-Targeted Interventions in Chronic Kidney Disease

Jiangwa Xing, Yi You, Mingxiao Wang
article en

Abstract

Chronic kidney disease (CKD) has traditionally been understood from a glomerular perspective: proteinuria and a decline in estimated glomerular filtration rate (eGFR) are regarded as core hallmarks of the disease, and current intervention options for CKD are limited.Recent studies have highlighted the critical role of the gut-kidney axis in the pathogenesis and management of CKD; metabolomics has shown that the accumulation of conjugated bile acids is associated with declining renal function and cardiovascular risk, whereas elevated levels of primary bile acids are associated with a lower risk of the disease.Research data, primarily from animal and cell culture models, indicate that bile acids (BAs) can influence CKD through the nuclear farnesoid X receptor (FXR) and the membrane G protein-coupled bile acid receptor (TGR5),This article provides a systematic review centered on the gut-kidney-vascular axis mediated by bile acid metabolites, elucidating the mechanisms of bile acid homeostasis remodeling and tissue damage in CKD, and highlighting that disease modification requires simultaneous targeting of specific bile acid subtypes and their receptors, rather than relying solely on existing therapies.

Medicine insights.Vol. 3(6)
Zunyi Medical University (CN)
Good health and well-being
Drug Transport and Resistance Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon